Steven Cobourn
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Steven P.
Cobourn is Chief Financial Officer at NextCure, Inc. since 2018.
Formerly, Chief Financial Officer at Vaccinex, Inc. from 2014 to 2018.
Treasurer & Vice President-Finance at Otsuka America Pharmaceutical, Inc. from 2003 to 2014.
Completed undergraduate education at Drexel University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEXTCURE, INC. -.--% | 30/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Directeur Financier/CFO | 01/01/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| VACCINEX, INC. | Directeur Financier/CFO | 01/01/2018 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Directeur Financier/CFO | 01/04/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Vaccinex, Inc.
Vaccinex, Inc. BiotechnologyHealth Technology Discovers and develops targeted biotherapeutics | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national